KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Staar Surgical (STAA) Inventory (2016 - 2026)

Staar Surgical's Inventory history spans 17 years, with the latest figure at $58.4 million for Q1 2026.

  • For Q1 2026, Inventory rose 31.05% year-over-year to $58.4 million; the TTM value through Jan 2026 reached $58.4 million, up 31.05%, while the annual FY2026 figure was $58.4 million, 31.05% up from the prior year.
  • Inventory reached $58.4 million in Q1 2026 per STAA's latest filing, up from $53.3 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $58.4 million in Q1 2026 to a low of $19.6 million in Q2 2022.
  • Average Inventory over 5 years is $37.2 million, with a median of $38.6 million recorded in 2023.
  • Peak YoY movement for Inventory: skyrocketed 60.83% in 2023, then rose 15.39% in 2024.
  • A 5-year view of Inventory shows it stood at $25.8 million in 2022, then surged by 49.56% to $38.6 million in 2023, then increased by 15.39% to $44.6 million in 2024, then increased by 19.56% to $53.3 million in 2025, then rose by 9.61% to $58.4 million in 2026.
  • Per Business Quant, the three most recent readings for STAA's Inventory are $58.4 million (Q1 2026), $53.3 million (Q3 2025), and $55.2 million (Q2 2025).